Phase 2 Multicenter Randomized Study of DS-1062a in Advanced or Metastatic NSCLC w/ Actionable Genomic Alterations and Previously Treated with Kinase Inhibitor Therapy and Platinum-based Chemotherapy w/ or w/o Prior Immunotherapy

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.